The Potential Impact of the COVID-19 Pandemic on Global Antimicrobial and Biocide Resistance: an AMR Insights Global Perspective
Shamshul Ansari,John P. Hays,Andrew Kemp,Raymond Okechukwu,Jayaseelan Murugaiyan,Mutshiene Deogratias Ekwanzala,Maria Josefina Ruiz Alvarez,Maneesh Paul-Satyaseela,Chidozie Declan Iwu,Clara Balleste-Delpierre,Ed Septimus,Lawrence Mugisha,Joseph Fadare,Susmita Chaudhuri,Vindana Chibabhai,J. M. Rohini W. W. Wadanamby,Ziad Daoud,Yonghong Xiao,Thulasiraman Parkunan,Yara Khalaf,Nkuchia M. M'Ikanatha,Maarten B. M. van Dongen
DOI: https://doi.org/10.1093/jacamr/dlab038
2021-01-01
JAC-Antimicrobial Resistance
Abstract:The COVID-19 pandemic presents a serious public health challenge in all countries. However, repercussions of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections on future global health are still being investigated, including the pandemic's potential effect on the emergence and spread of global antimicrobial resistance (AMR). Critically ill COVID-19 patients may develop severe complications, which may predispose patients to infection with nosocomial bacterial and/or fungal pathogens, requiring the extensive use of antibiotics. However, antibiotics may also be inappropriately used in milder cases of COVID-19 infection. Further, concerns such as increased biocide use, antimicrobial stewardship/infection control, AMR awareness, the need for diagnostics (including rapid and point-of-care diagnostics) and the usefulness of vaccination could all be components shaping the influence of the COVID-19 pandemic. In this publication, the authors present a brief overview of the COVID-19 pandemic and associated issues that could influence the pandemic's effect on global AMR.